esophageal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Thoracic esophageal squamous cell carcinoma; 2. No antitumor therapy for esophageal cancer was performed; 3. Aged 18-75 years old; 4. Did not receive chemotherapy, radiotherapy or hormone therapy for malignant tumors, had no history of other malignant tumors, and did not include prostate cancer patients who received hormone therapy and obtained DFS for more than 5 years; 5. Physical state ECOG 0 ~ 2; 6. Subjects must understand and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Multiple primary cancer patients; 2. Mentally ill; 3. The patient already has or has concomitant hemorrhagic disease; 4. Women who are pregnant or breast-feeding.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| T1-4N0-3 bone metastasis rate of thoracic esophageal squamous cell carcinoma at different stages;T1-4N0-3 brain metastasis rate of thoracic esophageal squamous cell carcinoma at different stages; | — |
Secondary
| Measure | Time frame |
|---|---|
| ECT was used to examine the sensitivity, specificity, positive predictive value and negative predictive value of bone metastasis from esophageal squamous cell carcinoma;sensitivity, specificity, positive predictive value and negative predictive value of esophageal squamous cell carcinoma in plain brain scan + enhanced MRI; | — |
Countries
China
Contacts
Department of Thoracic Surgery, Cancer Hospital of Chinese Academy of Medical Sciences, Beijing, Chin